AzTrials
AzTrials

Persistent AsthmaACT MeNCT02176694

Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care

A study testing Text Messaging in people with Persistent Asthma, run by Children's Hospital Medical Center, Cincinnati at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized controlled trial of a texting intervention to increase adherence to preventative asthma medication in four Cincinnati Children's Hospital Medical Center primary care clinics. Read more about this study

Who is it for?
Ages 12 to 21 years
Conditions the study is for
Persistent Asthma
What is being tested?
Text Messaging
Could I receive a placebo?
No, everyone receives an active treatment
How many people
29 participants
Where
1 siteUnited States
Study dates
Jun 2014to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 21 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • provider-diagnosed persistent asthma
  • prescription of an ICS in accordance in NHLBI Expert Panel Report 3 guidelines for at least 30 days prior to enrollment
  • Asthma Control Test (ACT) score less than 20 (indicating lack of current control)
  • no provider-diagnosed exacerbation in the 30 days prior to enrollment
  • possession of a text-enabled cell phone and a plan to keep it throughout the study period
  • agreement by parents (or participants over 18 years old) to any charges levied by their cell phone carrier for text messages associated with the study if they do not have an unlimited texting plan
  • speak and read English

Who cannot join

  • another chronic lung disease (which would complicate measurement of asthma control)
  • cognitive or psychiatric disorder that the treating clinician judges would impair study participation
  • use of Advair diskus for their ICS (for which no reliable electronic monitor exists)
  • current enrollment in another asthma intervention study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45229

Other trials in United States

About this study

Official title: Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care.

A randomized controlled trial of a texting intervention to increase adherence to preventative asthma medication in four Cincinnati Children's Hospital Medical Center primary care clinics.

Read the detailed description

Our first aim is to determine the feasibility, acceptability and use of a low intensity text messaging intervention to improve adherence to inhaled corticosteroid (ICS) therapy among high risk adolescents with persistent asthma. Our second aim is to determine effect sizes of the intervention to improve adherence (As measured by electronic monitoring and self-report); clinical asthma control; and asthma related quality of life among adolescents with persistent asthma. Our third and final aim is to determine the temporal relationship between text message receipt and ICS canister actuation in order to understand mechanisms by which text messaging may increase ICS adherence.

Being tested
Text Messaging
Keywords
persistent asthma, adherence, text message reminders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Text MessagingBehavioural

    Website that allows adolescents to create, schedule and send one-time or recurring text messages that will serve as a reminder to take asthma medication or follow up with another health-related matter.

Study groups in NCT02176694
Study groupRoleWhat they receive
Standard CareNo interventionAside from the asthma education provided at enrollment and placement of the SmartInhaler (i.e.,electronic monitoring device), adolescents will continue to receive usual care through their primary care providers.
Text MessagingExperimentalA technology based system which allows adolescents to compose, schedule and send one-time or recurring text messages to their own cell phones.
Receives: Behavioral: Text Messaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Objective Adherence to ICS

    Electronic monitor logs

    Measured: Baseline

  2. Change in objective adherence to ICS

    Electronic Monitor Logs

    Measured: Change from baseline in objective adherence to ICS at 1 month

  3. Change in objective adherence to ICS

    Electronic Monitor Logs

    Measured: Continuous change over time from baseline in objective adherence to ICS at 2 months in intervention compared to control

  4. Change in objective adherence to ICS

    Electronic Monitor Logs

    Measured: Continuous change over time from baseline in objective adherence to ICS at 3 months in intervention compared to control

  5. Change in objective adherence to ICS

    Electronic Monitor Logs

    Measured: Continuous change over time from baseline in objective adherence to ICS at 4 months in intervention compared to control

  6. Change in objective adherence to ICS

    Electronic Monitor Logs

    Measured: Continuous change over time from baseline in objective adherence to ICS at 5 months in intervention compared to control

  7. Feasibility, Acceptability and Usability of the Text Messaging Website

    The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs.

    Measured: At time of text messaging intervention

  8. Feasibility, Acceptability and Usability of the Text Messaging Website

    The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs.

    Measured: up to 1 month after receiving text messages

  9. Feasibility, Acceptability and Usability of the Text Messaging Website

    The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs.

    Measured: up to 2 months after receiving text messages

  10. Feasibility, Acceptability and Usability of the Text Messaging Website

    The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs.

    Measured: up to 3 months after receiving text messages

Secondary outcomes (12)
  1. Asthma Control

    The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma.

    Measured: Baseline

  2. Change in Asthma Control

    The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma.

    Measured: Change from Baseline at 1 month

  3. Change in Asthma Control

    The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma.

    Measured: Continuous change over time from baseline at 2 months in intervention compared to control

  4. Change in Asthma Control

    The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma.

    Measured: Continuous change over time from baseline at 3 months in intervention compared to control

  5. Change in Asthma Control

    The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma.

    Measured: Continuous change over time from baseline at 4 months in intervention compared to control

  6. Change in Asthma Control

    The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma.

    Measured: Continuous change over time from baseline at 5 months in intervention compared to control

  7. Asthma Symptoms, Quality of Life, Treatment Barriers

    The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month.

    Measured: Baseline

  8. Change in Asthma Symptoms, Quality of Life, Treatment Barriers

    The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month.

    Measured: Change from Baseline at month 1

  9. Change in Asthma Symptoms, Quality of Life, Treatment Barriers

    The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month.

    Measured: Continuous change over time from baseline at 2 months in intervention compared to control

  10. Change in Asthma Symptoms, Quality of Life, Treatment Barriers

    The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month.

    Measured: Continuous change over time from baseline at 3 months in intervention compared to control

  11. Change in Asthma Symptoms, Quality of Life, Treatment Barriers

    The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month.

    Measured: Continuous change over time from baseline at 4 months in intervention compared to control

  12. Change in Asthma Symptoms, Quality of Life, Treatment Barriers

    The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month.

    Measured: Continuous change over time from baseline at 5 months in intervention compared to control

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2014 (estimated)
  2. Study startJun 2014
  3. Primary completionDec 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
29 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02176694
Sponsor's protocol ID
2013-1184
Other IDs
1R21HL119826-01
Acronym
ACT Me
Status last verified
Jun 2016
First submitted
9 Jun 2014
Last updated
10 Jun 2016
Results posted
No
Data monitoring committee
No

Publications

  • Dodds CM, Britto MT. Learnings from a pragmatic pilot trial of text messaging for high-risk adolescents with asthma. Ann Allergy Asthma Immunol. 2018 May;120(5):546-547. doi: 10.1016/j.anai.2018.02.008. Epub 2018 Feb 9. No abstract available.

    PubMed 29432968

Questions about this trial

What is this clinical trial studying?

A study testing Text Messaging in people with Persistent Asthma, run by Children's Hospital Medical Center, Cincinnati at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Objective Adherence to ICS (time frame: Baseline). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02176694, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in